Your browser doesn't support javascript.
loading
[Bronchoscopic intervention therapy for pulmonary mucormycosis with main bronchial occlusion: a case report].
Wu, X X; Wang, J; Jin, Y K; Lin, L; Qiu, X J; Zhang, J; Wang, T.
Affiliation
  • Wu XX; Department of Respiratory and Critical Care Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China.
  • Wang J; Department of Respiratory and Critical Care Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China.
  • Jin YK; Department of Respiratory and Critical Care Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China.
  • Lin L; Department of Respiratory and Critical Care Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China.
  • Qiu XJ; Department of Respiratory and Critical Care Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China.
  • Zhang J; Department of Respiratory and Critical Care Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China.
  • Wang T; Department of Respiratory and Critical Care Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China.
Zhonghua Jie He He Hu Xi Za Zhi ; 47(6): 550-553, 2024 Jun 12.
Article in Zh | MEDLINE | ID: mdl-38858206
ABSTRACT
Pulmonary mucormycosis is one of the most common types of mucormycosis. Tracheobronchial pulmonary mucormycosis primarily affects the tracheobronchial tree, causing lesions that can invade the airway mucosa and muscular layer, damaging the cartilage. It is characterised by acute onset, rapid progression, and high mortality rate, making clinical treatment challenging. This article reports the diagnosis and treatment of a patient with pulmonary mucormycosis complicated by left main bronchus occlusion. In addition to systemic treatment, which consisted mainly of an intravenous injection of amphotericin B combined with an oral suspension of posaconazole, the patient underwent multiple bronchoscopic interventions, including local infusion of amphotericin B under endoscopy, balloon dilation and silicone stent placement. After four months of comprehensive treatment, the therapeutic effect was satisfactory. This report demonstrates that bronchoscopic intervention therapy plays an important role in the comprehensive treatment of pulmonary mucormycosis, especially in preventing death from the progression to obstructive pneumonia.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bronchoscopy / Lung Diseases, Fungal / Mucormycosis Limits: Humans / Male / Middle aged Language: Zh Journal: Zhonghua Jie He He Hu Xi Za Zhi / Zhonghua jiehe he huxi zazhi Year: 2024 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bronchoscopy / Lung Diseases, Fungal / Mucormycosis Limits: Humans / Male / Middle aged Language: Zh Journal: Zhonghua Jie He He Hu Xi Za Zhi / Zhonghua jiehe he huxi zazhi Year: 2024 Type: Article Affiliation country: China